68.2% of patients were classified as having WR, and 31.8% of patients were classified as having IWL
CHPL leku Ozempic, roztwr do wstrzykiwa we wstrzykiwaczu, 2 mg Przeciwwskazania 4.3 Przeciwwskazania Nadwraliwo na substancj czynn lub na ktrkolwiek substancj pomocnicz wymienion w punkcie 6.1
A caution specific to this population: many patients starting these medications are deconditioned, older, or carry joint and cardiometabolic issues, so programs need sensible entry points and progression rather than a generic bodybuilding template
Studies suggest that some patients with diabetes may have a higher risk of clinically-significant gastroparesis if they are taking a semaglutide (such as Ozempic)
Studies on GLP-1 medications show that approximately 25-40% of weight lost can come from lean mass rather than fat mass
Common GLP-1s include liraglutide, semaglutide and tirzepatide and each is sold and marketed under a variety of other brand names, depending on their dosage and reason for use